This decrease is associated with the upregulation of FTO, which targets the heat shock factor 1-heat shock proteins (HSF1-HSPs) pathway, promoting the proliferation, migration, and invasion of multiple myeloma cells. The gene discussed is HSF1; the disease is plasma cell myeloma.